Tech Company Financing Transactions

Endocyte Funding Round

Endocyte closed a $26 million Series C funding round on 10/18/2009. Investors included Blue Chip Venture Company, Burrill & Company and IU Health Ventures.

Transaction Overview

Company Name
Endocyte
Announced On
10/18/2009
Transaction Type
Venture Equity
Amount
$26,000,000
Round
Series C
Investors

Blue Chip Venture Company (John Mcilwarith)

Burrill & Company (Ann Hanham)

IU Health Ventures (John Mutz)

Sanderling Ventures (Fred Middleton)

Triathlon Medical Ventures

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3000 Kent Ave.
West Lafayette, IN 47906
USA
Phone
(765) 463-7175
Website
www.endocyte.com
Email Address
[email protected]
Overview
Endocyte seeks to find new treatments for cancer that pair companion imaging agents with small molecule drug conjugates (SMDCs).
Profile
Endocyte LinkedIn Company Profile
Social Media
Endocyte Company Twitter Account
Company News
Endocyte News
Facebook
Endocyte on Facebook
YouTube
Endocyte on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Sherman
  Michael Sherman LinkedIn Profile  Michael Sherman Twitter Account  Michael Sherman News  Michael Sherman on Facebook
Chief Financial Officer
Michael Andriole
  Michael Andriole LinkedIn Profile  Michael Andriole Twitter Account  Michael Andriole News  Michael Andriole on Facebook
Chief Medical Officer
Alison Armour
  Alison Armour LinkedIn Profile  Alison Armour Twitter Account  Alison Armour News  Alison Armour on Facebook
Chief Scientific Officer
Philip Low
  Philip Low LinkedIn Profile  Philip Low Twitter Account  Philip Low News  Philip Low on Facebook
Vice President
Iontcho Vlahov
  Iontcho Vlahov LinkedIn Profile  Iontcho Vlahov Twitter Account  Iontcho Vlahov News  Iontcho Vlahov on Facebook
VP - Bus. Development
Matthew Call
  Matthew Call LinkedIn Profile  Matthew Call Twitter Account  Matthew Call News  Matthew Call on Facebook
VP - Finance
Beth Taylor
  Beth Taylor LinkedIn Profile  Beth Taylor Twitter Account  Beth Taylor News  Beth Taylor on Facebook
VP - Human Resources
Katherine Parker
  Katherine Parker LinkedIn Profile  Katherine Parker Twitter Account  Katherine Parker News  Katherine Parker on Facebook
VP - R & D
Christopher Leamon
  Christopher Leamon LinkedIn Profile  Christopher Leamon Twitter Account  Christopher Leamon News  Christopher Leamon on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/18/2009: Sometrics venture capital transaction
Next: 10/19/2009: QSpex Technologies venture capital transaction

 

Share this article

 

Where The Data Comes From

We report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.